top of page
About
Program Reports
Datasets
Annual Report
C/Can 2025
Astellas
Bristol-Myers Squibb
Chugai
Daiichi Sankyo
Eisai Co
Eli Lilly & Co
GSK
Merck & Co
Merck KGaA
Novartis
Novo Nordisk
Pfizer
Roche
Sanofi
Servier
Shionogi & Co
Sumitomo Dainippon
Takeda
African Consortium for Cancer Clinical Trials (AC3T)
Beyond Medicines in Ukraine
Blueprint for Innovative Healthcare Access
Instrumental Access Program (IAP): Building Research Capacity in LMICs
Lysosomal Storage Disorder Charitable Access Program
Max Access Solution (MAS)
Patient Assistance Program for Adcetris®
Patient Assistance Program (PAP) - Entyvio®
Patient Assistance Program (PAP) - Ninlaro®
R&D Access to Medicines Employee Fellowship Program
Active in 2020
Archived
bottom of page